Advertisement

Prohibitin: Mitochondrial Tumor Suppressor Protein

  • J. K. McClung

Abstract

The prohibitin story begins with the development of an assay for the detection of mRNAs that could inhibit the initiation of DNA synthesis.12 Messenger RNAs were tested by microinjecting them into individual human diploid fibroblasts that had been growth-arrested by serum restriction. The cells were then stimulated to undergo DNA replication by addition of serum to the media. Cells that had entered S phase or replicated DNA would incorporate [3H] thymidine into their nuclei. The labeled cells could be visualized by autoradiography. Two sources of mRNA (senescent human diploid fibroblasts and normal rat liver) contained mRNAs that inhibited DNA synthesis. My work focused on the inhibitory mRNA that was detected in normal rat liver.

Keywords

Breast Cancer Base Change Complementation Group Sporadic Breast Cancer Human Diploid Fibroblast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lumpkin Jr CK, McClung JK, Smith JR. Entry into S phase is inhibited in human fibroblasts by rat liver polyA+ RNA. Exp Cell Res 1985; 160:544-549.Google Scholar
  2. 2.
    Lumpkin Jr CK, McClung JK, Pereira-Smith OM et al. Existence of high abundance antiproliferative mRNAs in senescent human diploid fibroblasts. Science 1986; 232, 393-395.Google Scholar
  3. 3.
    Nuell MJ, Stewart DA, Walker L et al. Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Molec Cell Biol 1991; 11: 1372–1381.PubMedGoogle Scholar
  4. 4.
    McClung JK, Danner DB, Stewart DA et al. Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem Biophys Res Comm 1989; 164: 1316–1322.PubMedCrossRefGoogle Scholar
  5. 5.
    McClung JK, Jupe ER, Liu X-T et al. Prohibitin: Potential role in senescence, development, and tumor suppression. Exp Gerontol 1995; 3099-124.Google Scholar
  6. 6.
    White JJ, Ledbetter DH, Eddy RL et al. Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism. Genomics 1991; 11: 228–230.PubMedCrossRefGoogle Scholar
  7. 7.
    Black DM, Nicolai H, Borrow J et al. A somatic cell hybrid map of the long arm of human chromosome 17, containing the familial breast cancer locus (BRCA1). Am. J Hum Genet 1993; 52: 702–710.Google Scholar
  8. 8.
    Nagai MA, Yamamoto L, Salaorni S et al. Detailed deletion mapping of chromosome segment 17q12–21 in sporadic breast tumours. Genes Chromosome Cancer 1994; 11: 58–62.Google Scholar
  9. 9.
    Bowcock AM, Anderson LA, Friedman LS et al. THRA1 and D17S183 flank and interval of cM for the breast-ovarian cancer gene (BRCA 1) on chromosome 17g21. Am J Hum Genet 1993; 52: 718–722.Google Scholar
  10. 10.
    Sato T, Saito H, Swensen J et al. The human prohibitin gene located on chromosome 17821 is mutated in sporadic breast cancer. Cancer Res 1992; 52: 1643–1646.PubMedGoogle Scholar
  11. 11.
    Cliby W, Sarkar G, Ritland SR et al. Absence of prohibitin gene mutations in human epithelial ovarian tumors. Gynecol Oncol 1993; 50:34-37.Google Scholar
  12. 12.
    Tokino T, Davidson N, Helzlsouer K et al. Absence of germline prohibitin mutations in early onset breast cancer. Inter J Oncol 1993; 3: 769–722.Google Scholar
  13. 13.
    Jupe ER, Liu X-T, Keihlbauch JL et al. Prohibitin antiproliferative activity and loss of heterozygosity in immortalized cell lines. Exp Cell Res 1995; 218:577-580.Google Scholar
  14. 14.
    Jupe ER, Liu X-T, Kiehlbauch JL et al. The 3’Untranslated region of prohibitin and cellular immortalization. Exp Cell Res 1996; 224: 128–135.PubMedCrossRefGoogle Scholar
  15. 15.
    Jupe ER, Liu X-T, Kiehlbauch JL et al. Prohibitin in breast cancer cell lines loss of antiproliferative activity is linked to 3’ untranslated region mutations. 1996; Cell Growth Differen 7: 871–878.Google Scholar
  16. 16.
    Eveleth DDJ, Marsh JL. Sequence and expression of the Cc gene, a member of the dopa decarboxylasegene cluster of Drosophila: Possible translational regulation. Nucleic Acids Res 1986; 14: 6169–6183.PubMedCrossRefGoogle Scholar
  17. 17.
    Terashima M, Kim K-M, Adachi T et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J 1994; 13: 3782–3792.Google Scholar
  18. 18.
    Kaneko T, Sato S, Kotani H. Sequence analysis of the unicellularcyanobacterium Synechocystis sp strain PCC68o3. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res 1996; 3(3):1o9–136.Google Scholar
  19. 19.
    Sato T, Sakamoto T, Takita K-I et al. The human prohibitin (phb) gene family and its somatic mutations in human tumors. Genomics 1993; 17: 762–764.PubMedCrossRefGoogle Scholar
  20. 20.
    Nowak R. Breast cancer gene offers surprises. Science 1994; 2651796-1799.Google Scholar
  21. 21.
    Devilee P, Cornelisse CJ. Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1994; 1198: 113–130.Google Scholar
  22. 22.
    Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71.Google Scholar
  23. 23.
    Wooster R, Neuhausen SL, Mangion J. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13g12–13. Science 1994; 265: 2088–2090.Google Scholar
  24. 24.
    Knudson Jr AG. Retinoblastoma: a prototypic hereditary neoplasm. Cancer Res 1985; 45: 1437–1443.PubMedGoogle Scholar
  25. 25.
    Levine AJ. The tumor suppressor genes. Annu Rev Biochem 1993; 62: 623–651.Google Scholar
  26. 26.
    Futreal PA, Liu Q, Shattuck-Eidens D et al. BRCA1 mutations in primary breast and ovarian carcinomas, Science 1994; 266: 120–122.Google Scholar
  27. 27.
    Vogelstein B, Kinzler KW. Has the breast cancer gene been found. Cell 1994; 79: 1–3.Google Scholar
  28. 28.
    Theile M, Hartmann S, Scherthan H et al. Supression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene 1995; 10439–337.Google Scholar
  29. 29.
    Saito H, Inazawa J, Saito S et al. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 1993; 533382-3385.Google Scholar
  30. 30.
    Radford DM, Fair K, Thompson AM et al. Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res 1993; 53:2947-2950.Google Scholar
  31. 31.
    Thompson JD, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-4680 Google Scholar
  32. 32.
    Altus MS, Wood CM, Stewart DA et al. Regions of evolutionary conservation between the rat and human prohibitin-encoding genes. Gene 1995; 158: 291–294.Google Scholar
  33. 33.
    Ikonen E, Fiedler K, Parton RG et al. Prohibitin, an antiproliferative protein, is localized to mitochondria. FEBS Letters 1995; 358: 273–277.Google Scholar
  34. 34.
    Liu X-T, Stewart CA, King RL et al. Prohibitin expression during cellular senescence of human diploid fibroblasts. Biochem Biophys Res Comm 1994; 201409-414.Google Scholar
  35. 35.
    Lumpkin Jr CK, Moore TL, Tarpley MD et al. Acute ethanol and selected growth suppressor transcripts in regereating rat liver. Alcohol 1995; 12(4):357–362.Google Scholar
  36. 36.
    Roskams AJI, Friedman V, Wood CM et al. Cell cycle activity and expression of prohibitin mRNA. J Cell Physiol 1993; 157289-295.Google Scholar
  37. 37.
    Choongkittaworn NM, Kim KH, Danner DB et al. Expression of prohibitin in rat seminiferous epithelium. Bio Reproduc 1993; 49: 300–310.Google Scholar
  38. 38.
    Shay JW, Wright WE, Werbin H. Defining the molecular mechanisms of human cell immortalization Biochim Biophys Acta 1991; 1072: 1–7.Google Scholar
  39. 39.
    Cobrink D, Dowdy DF, Hinds PW et al. The retinoblastoma protein and the regulation of cell cycling TIBS 1992; 17312-315.Google Scholar
  40. 40.
    Stein GH, Yanishevsky RM. Entry into S phase is inhibited in two immortal cell lines fused to senescent human diploid cells Exp Cell Res 1979; 120: 155–165.Google Scholar
  41. 41.
    Jazwinski SM. Longevity, genes, and aging. Science 1996; 273: 54–59.Google Scholar
  42. 42.
    Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: Identification of four complementation groups. Proc. Natl Acad Sci USA 1988; 85: 6042–6046.PubMedCrossRefGoogle Scholar
  43. 43.
    Harris AL. p53 expression in human breast cancer. Adv Cancer Res 1992; 59:69–88.Google Scholar
  44. 44.
    Rastinejad F, Blau HM. Genetic complementation reveals a novel regulatory role for 3’ untranslated regions in growth and differentiation. Cell 1993; 72: 903–917.Google Scholar
  45. 45.
    Rastinejad F, Conboy MJ, Rando TA et al. Tumor suppression by RNA from the 3’ untranslated region of a-tropomyosin. Cell 1993; 75: 1107–1117.Google Scholar
  46. 46.
    Dell’Orco RT, Jupe ER, Manjeshwar S et al. Prohibitin: A new biomarker for breast tumor. Breast 1997; 3: 85–89.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • J. K. McClung

There are no affiliations available

Personalised recommendations